Expertise in
17
conditions

Dr. Brian Morrissey

Intensive Care Medicine
University Of California Davis
2825 J St Ste 400, 
Sacramento, CA 
Offers Telehealth
Referral may be required
Expertise in
17
conditions
University Of California Davis
2825 J St Ste 400, 
Sacramento, CA 

Overview

Brian Morrissey is an Intensive Care Medicine provider practicing medicine in Sacramento, California.

Dr. Morrissey is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Bronchiectasis, Acute Interstitial Pneumonia, Lung Metastases, and Endoscopy.

He is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 8 clinical trials.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

University Of California Davis Medical Center
Enloe Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 13 Less Insurance Carriers -

Locations

University of California Davis
2825 J St Ste 400, Sacramento, CA 95816
Other Locations
Office
4150 V St Ste 3400, Sacramento, CA 95817

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Terminated
Publish Date: November 13, 2025
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD
Enrollment Status: Unknown
Publish Date: June 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3/4 Study to Evaluate the Safety, Immunogenicity, and Effects on the Alpha1-Proteinase Inhibitor (A1PI) Levels in Epithelial Lining Fluid Following Glassia Therapy in A1PI-Deficient Subjects
A Phase 3/4 Study to Evaluate the Safety, Immunogenicity, and Effects on the Alpha1-Proteinase Inhibitor (A1PI) Levels in Epithelial Lining Fluid Following Glassia Therapy in A1PI-Deficient Subjects
Enrollment Status: Completed
Publish Date: October 14, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 7 Less Clinical Trials

21 Total Publications

α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.
α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.
Journal: Nutrients
Published: August 16, 2022
Similar Doctors
Expertise in
11
conditions
Dr. Namita Sood
Intensive Care Medicine
Expertise in
11
conditions
Dr. Namita Sood
Intensive Care Medicine

University Of California Davis

2825 J St Ste 400, 
Sacramento, CA 
 (0.2 miles away)
916-734-0779
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Namita Sood is an Intensive Care Medicine provider practicing medicine in Sacramento, California. Dr. Sood is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Pulmonary Veno-Occlusive Disease.

Expertise in
10
conditions
Dr. Mark Avdalovic
Intensive Care Medicine
Expertise in
10
conditions
Dr. Mark Avdalovic
Intensive Care Medicine

University Of California Davis

2825 J St Ste 400, 
Sacramento, CA 
 (0.2 miles away)
916-734-0779
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Avdalovic is an Intensive Care Medicine provider practicing medicine in Sacramento, California. Dr. Avdalovic is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, and Bone Marrow Aspiration.

Expertise in
14
conditions
Dr. Richart Harper
Intensive Care Medicine
Expertise in
14
conditions
Dr. Richart Harper
Intensive Care Medicine

Office

4150 V St Ste 3400, 
Sacramento, CA 
 (1.7 miles away)
916-734-3566
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richart Harper is an Intensive Care Medicine provider practicing medicine in Sacramento, California. Dr. Harper is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Neurosarcoidosis, Acute Interstitial Pneumonia, Liver Embolization, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Brian Morrissey

How do I make an appointment with Dr. Brian Morrissey?

You can book an appointment with Dr. Brian Morrissey by calling their office at 916-734-0779. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brian Morrissey a top-rated expert for Cystic Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brian Morrissey is classified as an Distinguished expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brian Morrissey specialize in?

While Dr. Brian Morrissey is a Intensive Care Medicine, they have specific expertise in Cystic Fibrosis, Bronchiectasis, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Brian Morrissey participate in research or clinical trials?

Yes. Dr. Brian Morrissey has published 21 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Brian Morrissey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Brian Morrissey accept my insurance?

Dr. Brian Morrissey accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 916-734-0779 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Morrissey's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile